top of page


AGC Biologics expands dual-site pharmaceutical manufacturing contract to more than €500 million
AGC Biologics has expanded a long-term manufacturing agreement with an unnamed global pharmaceutical company to more than €500 million, adding six commercial biologics programmes at its Copenhagen facility.

nuaxia
Nov 42 min read


ADCAN Pharma and Pinnacle Life Science agree licensing and technology-transfer deal for 12 oncology products
ADCAN Pharma and Pinnacle Life Science have entered into a licensing and technology-transfer partnership covering 12 oncology products and their planned local manufacture in the UAE.

nuaxia
Sep 31 min read
bottom of page